Revance Therapeutics (RVNC) Operating Margin (2014 - 2024)
Revance Therapeutics (RVNC) operating margin from Mar 31, 2014 to Sep 30, 2024. The current Revance Therapeutics (RVNC) operating margin is -53.87%. You can export chart.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Revance Therapeutics (RVNC)
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -135.35% | -47.53% |
| 2022 | -257.95% | -26.94% |
| 2021 | -353.06% | -80.19% |
| 2020 | -1781.87% | -95.56% |
| 2019 | -40112.20% | +949.00% |
| 2018 | -3823.86% | -91.74% |
| 2017 | -46315.38% | +57.52% |
| 2016 | -29403.33% | +21.97% |
| 2015 | -24106.67% | +75.99% |
| 2014 | -13697.37% | N/A |
Comparison Revance Therapeutics (RVNC) operating margin with competitors
Revance Therapeutics (RVNC) operating margin is -53.87%.